New Key Statistics Module, Z-Score and F-Score
NAS:PBAXU Key Ratios
Market Cap $ M | -- |
Enterprise Value $ M | -- |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -- |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -9.80 |
EV-to-EBITDA | -9.80 |
PEG | -- |
Shares Outstanding M | -- |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 1.76 |
Current Ratio | 1.76 |
ROA % (ttm) | -4.84 |
ROE % (ttm) | -7.41 |
ROIC % (ttm) | -10.30 |
Dividend Yield % | -- |
Altman Z-Score | -- |
PBAXU Number of Guru Trades
PBAXU Volume of Guru Trades
Gurus Latest Trades with NAS:PBAXU
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PBAXU is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Phoenix Biotech Acquisition Corp Insider Transactions
No Available Data
News about NAS:PBAXU
Total 0- 1